UiPath Just Ripped 32% in a Month — So Why Did the CEO Cash Out $22.5 Million the Second It Got There?
⚠️ Not financial advice. This post is for informational and educational purposes only. Forecasts and commentary are model outputs and opinions, may be inaccurate, and are not a recommendation to buy or sell any security or asset. Do your own research. AI-assisted: this article was drafted with AI and reviewed by a human before publishing.
# UiPath Just Ripped 32% in a Month — So Why Did the CEO Cash Out $22.5 Million the Second It Got There?
Let's start with the number that should make you sit up: UiPath went from $12.15 on July 17 to $16.01 by August 14. That's a 32% move in a single month, on a stock that had spent most of the year grinding sideways in what one chart-watcher generously called a "choppy base." Q2 fiscal 2026 earnings landed the punch — $362 million in revenue, up 14% year-over-year, ARR pushing past $1.7 billion, and actual positive free cash flow. For a company that's spent years being the poster child of "great product, messy financials," that's a real result, not vibes.
And then, five days after the stock topped $16, CEO Daniel Dines sold 1.4 million shares for $22.5 million.
That's the whole story of UiPath right now, distilled into one uncomfortable juxtaposition: the business is showing genuine signs of life, and the guy who runs it is taking chips off the table right as the market finally agrees with him.
The Bull Case Isn't Fake
Give credit where it's due. Revenue growth is holding in the mid-teens, ARR is compounding at 11%, and management has rolled out Maestro, its orchestration layer for "agentic automation" — the industry's preferred euphemism for AI agents that actually do work instead of just chatting about it. UiPath is trying to reposition itself from "RPA vendor that automates spreadsheets" to "platform that orchestrates AI agents across the enterprise," and if that repositioning sticks, the total addressable market conversation changes entirely. Layer on a $500 million buyback and a real shot at UiPath's first full year of GAAP profitability in FY2026, and you've got a legitimate turnaround narrative — not the zombie-stock kind, the "actually check the numbers" kind.
But Read the Room on Valuation
Here's the part that should temper your enthusiasm: the median 12-month price target across 20 Wall Street analysts sits at $13, with a range of $11 to $17. The stock is trading at $16. That means the Street, collectively, thinks UiPath has already run past where it's supposed to be — and Zacks has it parked at a Hold. When your stock is above the median analyst target the week after a 32% rally, that's not a green light, that's a caution flag with a bow on it.
Then there's the competitive picture. Microsoft, Google, and Salesforce are all building agentic automation directly into platforms enterprises already pay for. UiPath's moat has always been stickiness — once you've automated your back office on their platform, ripping it out is painful — but "sticky" and "irreplaceable" aren't the same word, and hyperscalers bundling agentic AI for free (or near-free) inside tools customers already own is exactly the kind of slow-motion disintermediation that kills mid-cap software companies without anyone noticing until it's too late.
The Insider Sale Is the Tell
Insider sales happen for a hundred boring reasons — tax planning, diversification, pre-scheduled 10b5-1 plans. Fine. But timing matters to markets even when it shouldn't matter to lawyers, and a $22.5 million sale landing five days after a 32% rally, right as the stock cleared every recent resistance level, is not a great optics moment for a company trying to convince investors this rally has legs. If Dines truly believed Maestro and the agentic pivot were about to unlock a re-rating, the disciplined move is to let it ride. He didn't.
Bottom Line
UiPath's fundamentals genuinely improved this quarter — that's not spin, that's the print. But the stock priced in the good news faster than the Street's models could catch up, insider selling right at the top isn't a vote of confidence, and the competitive runway from Microsoft and friends is only getting narrower. This isn't a stock to chase after a 32% sprint. It's one to watch for the next pullback and see whether Dines shows up as a buyer — because until he does, the market's getting more excited about UiPath's turnaround than its own CEO is.
More on PATH
Market commentary from the K3vl4r desk — not personalized investment advice. More posts →